Study guide
10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
Key Takeaways Explain This Topic AI
Intrusive thoughts in postpartum OCD are egodystonic, horrifying to the mother, and drive avoidance of the infant, whereas psychotic thoughts are egosyntonic and acted upon.
Postpartum psychosis occurs in 1 to 2 per 1,000 births, typically presents within days 3 to 14, and is a psychiatric emergency requiring immediate hospitalization.
Bipolar disorder is the strongest risk factor for postpartum psychosis, and a known history warrants proactive prophylaxis planning.
Sertraline is a commonly preferred SSRI in lactation because of low relative infant dose, and antidepressant response requires 4 to 6 weeks at an adequate dose.
A mother with postpartum psychosis must never be left alone with her infant, and the risk includes both infanticide and suicide.
Last updated: September 2026
- Evidence-Based Treatment Pathways for PPD Postpartum Depression Management Pathway
- ├── Mild to Moderate PPD (EPDS 10 - 14)
- │ ├── First-Line: Evidence-Based Psychotherapy
- │ │ ├── Cognitive Behavioral Therapy (CBT - cognitive restructuring)
- │ │ └── Interpersonal Psychotherapy (IPT - role transitions & support)
- │ └── Non-Pharmacologic: Peer support groups, protected sleep, structured aerobic exercise
- └── Moderate to Severe PPD (EPDS ≥15 or Refractory)
- ├── Combined Treatment: Psychotherapy PLUS Pharmacotherapy
- ├── Selective Serotonin Reuptake Inhibitors (SSRIs)
- │ ├── Sertraline (Zoloft) 25 - 50 mg PO daily, titrate to 100 - 200 mg (PREFERRED)
- │ └── Escitalopram (Lexapro) or Paroxetine (Paxil) (Alternatives)
- └── Neuroactive Steroids (Severe Acute PPD)
- └── Zuranolone (Zurzuvae) 50 mg PO daily in evening with fat meal x 14 days
- 1. Evidence-Based Psychotherapy
Cognitive Behavioral Therapy (CBT): The most extensively validated psychological treatment for perinatal depression. Targets and restructures negative cognitive distortions, automatic catastrophizing thoughts, and maladaptive perfectionism regarding motherhood.
Interpersonal Psychotherapy (IPT): Focuses on maternal role transitions, resolving marital/interpersonal conflict, and expanding social support networks.
2. Selective Serotonin Reuptake Inhibitors (SSRIs) & Lactation Safety
Pharmacotherapy is indicated for moderate-to-severe PPD, marked functional impairment, suicidal ideation, or when psychotherapy alone is inadequate.
Sertraline (Zoloft) — The Gold Standard:
The preferred first-line SSRI in breastfeeding women.
Pharmacokinetics: High plasma protein binding (98%) and extensive hepatic clearance result in minimal excretion into human breast milk. The Relative Infant Dose (RID) is consistently <2% (well below the accepted 10% safety threshold), and infant serum concentrations are undetectable in over 90% of tested infants.
Dosing: Initiate at 25 to 50 mg PO daily in the morning with food; titrate in 25–50 mg increments every 1 to 2 weeks up to an effective therapeutic dose of 100 to 200 mg daily. Full therapeutic antidepressant response typically requires 4 to 6 weeks.
Alternative SSRIs:
Paroxetine (Paxil): Also has very low breast milk transmission (RID 1% to 2%), but carries higher sedation and anticholinergic side effects; associated with challenging discontinuation syndromes.
Escitalopram (Lexapro) & Citalopram (Celexa): Low to moderate milk excretion (RID 3% to 7%); excellent options if the patient had prior successful response.
Fluoxetine (Prozac): Has a very long elimination half-life and an active metabolite (norfluoxetine) that accumulates in breast milk (RID 5% to 9%). Can cause transient infant irritability, colic, or loose stools. If a mother was stabilized on fluoxetine during pregnancy, she may continue it; however, it is generally not initiated de novo during lactation.
Infant Monitoring: Counsel lactating mothers on SSRIs to monitor the infant for feeding difficulties, excessive somnolence, irritability, or poor weight gain.
3. Neuroactive Steroid Therapeutics (GABA Modulators)
Zuranolone (Zurzuvae): First FDA-approved oral neuroactive steroid for the treatment of postpartum depression in adults.
Mechanism: Positive allosteric modulator of GABA A \text{GABA}_\text{A} GABA A receptors, rapidly restoring neural inhibition disrupted by allopregnanolone withdrawal.
Dosing: 50 mg orally once daily in the evening taken with a meal containing fat for a completed 14-day course .
Clinical Advantage: Rapid onset of significant antidepressant action observed as early as Day 3 , maintaining efficacy after treatment completion.
Adverse Effects & Safety: CNS depression (somnolence, dizziness, sedation). Patients must be instructed not to drive or operate machinery for at least 12 hours following each evening dose. Human lactation data is limited; clinicians should engage in shared decision-making regarding temporary pumping and discarding during the active 14-day window if maximal caution is desired.
Brexanolone (Zulresso): Continuous 60-hour intravenous infusion of allopregnanolone requiring inpatient admission and continuous pulse oximetry monitoring for excessive sedation and loss of consciousness.
- Postpartum Anxiety & Obsessive-Compulsive Disorder (OCD)
- Postpartum Generalized Anxiety & Panic
Postpartum anxiety affects up to 10% to 15% of women, characterized by persistent, excessive worries regarding infant health, autonomic hyperarousal, shortness of breath, trembling, and panic attacks.
Postpartum OCD & Intrusive Thoughts
Between 70% and 90% of all postpartum women experience occasional intrusive thoughts regarding harm befalling their baby. In postpartum OCD, these thoughts become pervasive, distressing, and debilitating.
The Critical Clinical Distinction: Egodystonic vs. Egosyntonic Thoughts
The certified nurse-midwife must master the distinction between obsessive intrusive thoughts and psychotic delusions. Misidentifying intrusive thoughts as psychosis results in traumatic, unnecessary psychiatric hospitalizations and inappropriate child separation.
Clinical Characteristic Egodystonic Intrusive Thoughts (Postpartum OCD / Anxiety) Egosyntonic Psychotic Delusions (Postpartum Psychosis)
Nature of Thought Unbidden, horrifying, repetitive thoughts or images of infant harm (e.g., dropping the baby, knife accidents, drowning in the bath) Fixed, bizarre, irrational beliefs regarding the infant (e.g., infant is possessed by a demon, infant is dead, divine purification)
Maternal Perception Repulsive, grotesque, terrifying, and deeply upsetting to the mother; recognized as completely foreign and contrary to her desires Believed to be absolutely real, rational, or divinely commanded ; patient does not question their validity
Emotional Response Intense guilt, shame, profound anxiety, weeping, and horror Lack of insight, paranoia, emotional detachment, euphoria, or acute agitation
Behavioral Impact Compulsive avoidant behaviors (e.g., refusing to hold baby near stairs, hiding knives, checking breathing repeatedly) Behaviors directed toward executing delusions; high risk of deliberate action
Infanticide Risk VIRTUALLY ZERO RISK of intentional infant harm EXTREMELY HIGH RISK (up to 4%) of infanticide
Midwifery Management Reassurance, psychoeducation, CBT with Exposure & Response Prevention (ERP), SSRIs EMERGENT PSYCHIATRIC HOSPITALIZATION ; immediate infant separation from mother
Postpartum Psychosis: The Ultimate Psychiatric Emergency
Postpartum psychosis (puerperal psychosis) is a severe, rapidly decompensating psychiatric emergency that demands immediate clinical action.
Epidemiology & Chronology
Incidence: Occurs in 1 to 2 per 1,000 live births (0.1% to 0.2%) .
Onset: Characteristically acute and abrupt, presenting within the first 2 to 4 weeks postpartum , with most cases emerging between postpartum days 3 and 14 .
Primary Risk Factor: Prior personal history of Bipolar I Disorder carries an astonishing 25% to 50% risk of postpartum psychosis. A prior history of postpartum psychosis carries an equivalent recurrence risk in subsequent pregnancies. Family history of bipolar disorder is also a major predisposing factor.
Clinical Presentation
Early Prodrome: Severe, intractable insomnia with complete absence of fatigue, restlessness, mood lability, and marked cognitive confusion.
Full Psychotic Syndrome:
Cognitive Delirium: Waxing and waning sensorium, disorientation to time and place, memory deficits, and extreme perplexity.
Bizarre Delusions: Egosyntonic, fixed false beliefs focused on the baby (e.g., the infant is demonic, possessed, deformed, or must be sacrificed for spiritual cleansing).
Hallucinations: Auditory command hallucinations instructing the mother to harm herself or kill the infant; visual or olfactory hallucinations.
Manic / Mixed States: Rapid, pressured speech, flight of ideas, psychomotor agitation, disorganized behavior, and extreme paranoia.
Mortality Risk: If untreated, postpartum psychosis carries a 4% rate of infanticide and a 5% rate of maternal suicide .
Emergency Midwifery Management Protocol
When postpartum psychosis is suspected, the CNM must execute an immediate, non-negotiable safety and crisis protocol:
ENSURE IMMEDIATE INFANT SAFETY:
The mother must NEVER be left unattended or alone with the infant under any circumstances.
Immediately place the infant in the custody of a safe, trusted partner, family member, or hospital nursery staff.
Immediate Emergency Psychiatric Evaluation:
Do not schedule an outpatient referral. Escort the patient directly to the nearest Emergency Department or psychiatric crisis evaluation center.
Inpatient Psychiatric Hospitalization:
Secure immediate admission to a locked inpatient psychiatric unit (ideally a specialized perinatal Mother-Baby Psychiatric Unit if available).
Pharmacotherapy:
Initiate second-generation atypical antipsychotics (olanzapine, quetiapine, risperidone), mood stabilizers (lithium, divalproex sodium), and short-term benzodiazepines for acute behavioral agitation.
Electroconvulsive Therapy (ECT): Recognized as a rapid, exceptionally safe, and highly effective treatment of choice for severe or medication-refractory postpartum psychosis, particularly in the presence of catatonia, severe mania, or acute suicidal/infanticidal delirium.